Citation	Subject	Subject Label	Predicate	Object	Object Label	Qualifier	Subject Qualifier	Subject Extension	Object Extension	Count
10587981	MAXO:0001001	Gene therapy	TREATS	HP:0002664	cancer	MONDO:0004992				2
9806008	MAXO:0001001	Gene therapy	TREATS	HP:0002664	cancer	MONDO:0004992				2
17721875	MAXO:0001001	Gene therapy	TREATS	adenosine deaminase deficiency		MONDO:0007064				2
9806008	MAXO:0001001	Gene therapy	TREATS	adenosine deaminase deficiency		MONDO:0007064				2
11060694	MAXO:0001001	Gene therapy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		gene therapy		2
27267267	MAXO:0001001	Gene therapy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		gene therapy		2
12901330	MAXO:0001001	Gene therapy	TREATS	primary immunodeficiencies						2
11434885	MAXO:0001001	Gene therapy	TREATS	primary immunodeficiencies						2
22447032	Treatment with high-dose intravenous corticosteroids		TREATS	inflammatory lesions in the brain and spinal cord		MONDO:0019383	high-dose intravenous	CHEBI:50858		2
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	adenosine deaminase deficiency-related severe combined immunodeficiency (ADA-SCID)						1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Shwachman-Bodian-Diamond syndrome (SBDS)				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Gaucher disease (GD) type III				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Duchenne (DMD) and Becker muscular dystrophy (BMD)				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Parkinson disease (PD)				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Huntington disease (HD)				CHEBI:17660		1
18691744	generation of		TREATS	juvenile-onset, type 1 diabetes mellitus (JDM)				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Down syndrome (DS)/trisomy 21				CHEBI:17660		1
18691744	generation of induced pluripotent stem (iPS) cells		TREATS	Lesch-Nyhan syndrome		MONDO:0010298		CHEBI:17660		1
10774451	MAXO:0001001	Gene therapy	TREATS	adenosine deaminase deficiency						1
10774451	umbilical cord blood HSC transduction		TREATS	adenosine deaminase deficiency			with murine retroviral-based vectors			1
10774451	neonatal bone marrow HSC transduction		TREATS	adenosine deaminase deficiency			with murine retroviral-based vectors	murine retroviral-based vectors		1
10774451	HSC engraftment		TREATS	adenosine deaminase deficiency						1
30014500	Treatment		TREATS	HP:0004430	Severe combined immunodeficiency	Adenosine Deaminase Deficiency With HCV		CHEBI:85082		1
30014500	MAXO:0001001	gene therapy	TREATS	HP:0004430	Severe combined immunodeficiency	Adenosine Deaminase Deficiency With HCV		Strimvelis		1
18221464	bone marrow/stem cell transplantation		TREATS	HP:0001508	failure to thrive	MONDO:0015974				1
18221464	bone marrow/stem cell transplantation		TREATS	HP:0002719	recurrent infections	MONDO:0015974		bone marrow/stem cell transplantation		1
27129325	transplant		TREATS	HP:0004430	Severe combined immunodeficiency	MONDO:0007064		Hematopoietic stem cell		1
27129325	Enzyme replacement therapy		TREATS	HP:0002721	Immune deficiency	MONDO:0007064	partially	Enzyme replacement therapy		1
27129325	MAXO:0001001	gene therapy	TREATS	HP:0002721	Immune deficiency	MONDO:0007064	with GSK2696273	GSK2696273	severe	1
27129325	Normalization of T-cell subsets		TREATS	HP:0002721	Immune deficiency	MONDO:0007064				1
27129325	Immunoglobulin production		TREATS	HP:0002721	Immune deficiency	MONDO:0007064		Immunoglobulin production		1
27129325	Decreased intravenous immunoglobulin use		TREATS	immunodeficiency		Adenosine deaminase deficiency	Decreased	intravenous immunoglobulin		1
27129325	Antibody response after vaccination		PREVENTS	infections		MONDO:0007064		vaccination		1
28895850	Transfer of gene-corrected autologous hematopoietic stem cells		TREATS	Primary Immunodeficiencies						1
28895850	Use of safer viral vectors		PREVENTS	Occurrence of malignancies		Primary Immunodeficiencies		safer viral vectors		1
27750026	Gene therapy with Hematopoietic Stem Cells		TREATS	inherited diseases		Gene Therapy with Hematopoietic Stem Cells related diseases		Gene transfer	Hematopoietic Stem Cells	1
10908569	low-dose enzyme therapy		TREATS	severe pulmonary insufficiency		MONDO:0007064	low-dose	enzyme therapy		1
10908569	high-dose enzyme therapy		TREATS	HP:0005387	combined immunodeficiency	MONDO:0007064	high-dose	enzyme therapy		1
10908569	high-dose enzyme therapy		TREATS	metabolic disturbances in the thymus and spleen		MONDO:0007064	high-dose	enzyme therapy		1
10908569	low-dose enzyme therapy		TREATS	metabolic disturbances in the circulation and lung		MONDO:0007064	low-dose	enzyme therapy		1
14612670	Gene therapy using peripheral blood lymphocytes		TREATS	lack of T cell functions		Severe combined immunodeficiency due to adenosine deaminase deficiency		Gene therapy		1
14612670	MAXO:0001001	gene therapy	TREATS	lack of antibody responses to neoantigen		MONDO:0007064	using hematopoietic progenitors	hematopoietic progenitors		1
14612670	Discontinuation of PEG-ADA		TREATS	metabolic defect		MONDO:0007064		PEG-ADA		1
14612670	Low-dose busulfan		PREVENTS	metabolic defect		MONDO:0007064	low-dose	CHEBI:28901		1
14612670	Nonmyeloablative conditioning		PREVENTS	metabolic defect		Severe combined immunodeficiency due to adenosine deaminase deficiency		Nonmyeloablative conditioning	metabolic defect	1
24823313	gene therapy		TREATS	T cell immunodeficiency		inherited immunodeficiency		gene therapy		1
24823313	ex vivo gene transfer into autologous hematopoietic stem cells (HSCs)		TREATS	T cell immunodeficiency		inherited immunodeficiency		viral vectors		1
24823313	development		PREVENTS	genotoxicity		inherited immunodeficiency		safer self-inactivating vectors		1
24823313	lentiviral transduction		TREATS	T cell immunodeficiency		inherited immunodeficiency				1
24823313	allogeneic HSC transplantation		TREATS	T cell immunodeficiency		inherited immunodeficiency		allogeneic HSC transplantation		1
10329842	Stimulation		TREATS	IgE synthesis				anti-CD3 monoclonal antibody	Increased expression of IL-4 and CD40 ligand mRNA	1
10329842	Autologous T cell-directed gene therapy		TREATS	IgE synthesis				Autologous T cell-directed gene therapy	Increased expression of IL-4 and CD40 ligand mRNA	1
10329842	Stimulation		TREATS	Production of IgE and IgG		IgE synthesis	with recombinant IL-4	anti-CD3 monoclonal antibody	IgE and IgG	1
15640693	MAXO:0010030	bone marrow transplantation	TREATS	HP:0004430	Severe combined immunodeficiency	MONDO:0003778				1
15640693	enzyme replacement		TREATS	adenosine deaminase deficiency		MONDO:0003778		enzyme replacement		1
15640693	MAXO:0001001	gene therapy	TREATS	HP:0004430	Severe combined immunodeficiency	MONDO:0003778	with IL2RG complementary DNA	IL2RG complementary DNA		1
15640693	MAXO:0001001	gene therapy	TREATS	adenosine deaminase deficiency		MONDO:0003778	with adenosine deaminase gene complementary DNA	adenosine deaminase gene complementary DNA		1
15640693	autologous hematopoietic stem cells transduction		TREATS	HP:0004430	Severe combined immunodeficiency	MONDO:0003778				1
15640693	transduction		TREATS	adenosine deaminase deficiency		MONDO:0003778		autologous hematopoietic stem cells		1
15640693	anti-leukemic treatment		TREATS	leukemia		primary immunodeficiencies		anti-leukemic		1
15640693	submyeloablative chemotherapy		TREATS	adenosine deaminase deficiency		primary immunodeficiencies		submyeloablative chemotherapy		1
33974366	Autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) transduced ex vivo		TREATS	life-threatening primary immunodeficiency		MONDO:0007064		a self-inactivating lentiviral vector encoding human ADA		1
33974366	enzyme-replacement therapy		PREVENTS	absent or impaired metabolic detoxification		MONDO:0007064		enzyme-replacement therapy		1
33974366	rescue allogeneic hematopoietic stem-cell transplantation		PREVENTS	compromised immune reconstitution		MONDO:0007064	rescue	allogeneic hematopoietic stem-cell transplantation		1
33974366	immunoglobulin-replacement therapy		TREATS	compromised immune reconstitution		MONDO:0007064		immunoglobulin		1
29744787	Enzyme replacement therapy		TREATS	higher levels		MONDO:0007064		Enzyme replacement therapy	ADA metabolite	1
29744787	Enzyme replacement therapy (ERT)		TREATS	T-B-NK- phenotype		MONDO:0007064	with	Pegylated ADA		1
29744787	Enzyme replacement therapy (ERT)		TREATS	T-B-NK+ phenotype		MONDO:0007064		Enzyme replacement therapy		1
29744787	Enzyme replacement therapy (ERT)		IMPROVES	gastrointestinal polyposis		MONDO:0007064		Enzyme replacement therapy		1
29744787	Intermittent neurodevelopmental evaluation		TREATS	HP:0000365	Hearing impairment	MONDO:0007064				1
29744787	Intermittent neurodevelopmental evaluation		MITIGATES	HP:0000750	Speech delay	MONDO:0007064				1
29744787	Intermittent neurodevelopmental evaluation		MITIGATES	HP:0100543	Cognitive abnormalities	MONDO:0007064				1
26682746	Impulse oscillometry		IDENTIFIES	Peripheral airway dysfunction		Adenosine deaminase-deficient severe combined immunodeficiency				1
26682746	Repetitive radiography		MONITORS	Pulmonary dysfunction		MONDO:0007064	Repetitive	Radiography		1
9857368	In vivo gene therapy		TREATS	neurological disorders		Central Nervous System Disorders		gene therapy	neurological disorders	1
28194615	MAXO:0000747	Hematopoietic stem cell transplantation	TREATS	ADA SCID		NA	from a human leukocyte antigen-matched sibling or family member	NA	NA	1
28194615	allogeneic HSCT from a matched unrelated donor		TREATS	ADA SCID			allogeneic	HSCT		1
28194615	allogeneic HSCT		TREATS	ADA SCID			from a haplo-identical donor			1
28194615	autologous HSCT with gene correction of the hematopoietic stem cells		TREATS	ADA SCID				gene therapy-GT		1
28194615	enzyme replacement therapy (ERT)		TREATS	ADA SCID				polyethylene glycol-conjugated adenosine deaminase		1
19099832	direct immunofluorescence assay		PREVENTS	disseminated varicella infection		adenosine deaminase deficiency associated severe combined immunodeficiency				1
19099832	MAXO:0000068	transplantation	TREATS	adenosine deaminase deficiency associated severe combined immunodeficiency		adenosine deaminase deficiency associated severe combined immunodeficiency		hematopoietic stem cell		1
19099832	enzyme replacement therapy		TREATS	adenosine deaminase deficiency associated severe combined immunodeficiency				enzyme replacement therapy		1
19099832	MAXO:0001001	gene therapy	TREATS	adenosine deaminase deficiency associated severe combined immunodeficiency						1
19179314	Gene therapy		TREATS	severe combined immunodeficiency		Immunodeficiency due to adenosine deaminase deficiency		autologous CD34+ bone marrow cells transduced with a retroviral vector containing the ADA gene		1
19179314	Nonmyeloablative conditioning		TREATS	lack of adenosine deaminase		Immunodeficiency due to adenosine deaminase deficiency	with busulfan	CHEBI:28901		1
19179314	Infusion of the cells		TREATS	fatal disorder of purine metabolism and immunodeficiency		Immunodeficiency due to adenosine deaminase deficiency		cells		1
19895994	Hematopoietic stem cell transplantation		TREATS	immune deficiency		MONDO:0015974		Hematopoietic stem cell		1
19895994	Pretransplantation conditioning		TREATS	engraftment failure		MONDO:0015974				1
19895994	Intravenous immunoglobulin		TREATS	HP:0002721	Immune deficiency	MONDO:0015974	intravenously administered	immunoglobulin		1
24794685	MAXO:0001479	Allogeneic hematopoietic stem cell transplantation	TREATS	absent or greatly reduced numbers of functional T cells		MONDO:0015974				1
24794685	Preparative conditioning		PREVENTS	complications		MONDO:0015974				1
24794685	Additional transplantation procedures		TREATS	complications		MONDO:0015974	Additional	transplantation procedures		1
10587981	MAXO:0001001	Gene therapy	TREATS	genetic diseases		MONDO:0003847				1
10587981	targeting		TREATS	adenosine deaminase deficiency		MONDO:0003847		Hematopoietic stem cell		1
10587981	Hematopoietic stem cell targeting		TREATS	chronic granulomatous disease		Genetic diseases		Hematopoietic stem cell		1
10587981	Retrovirus-mediated gene transfer		TREATS	adenosine deaminase deficiency		MONDO:0003847		Retrovirus-mediated gene transfer		1
10587981	Retrovirus-mediated gene transfer		TREATS	chronic granulomatous disease		MONDO:0003847				1
10587981	Introduction of drug-resistance genes		PREVENTS	side-effects		MONDO:0004992		drug-resistance genes	toxic side-effects	1
22350222	enzyme replacement		TREATS	metabolic abnormalities		Non-infectious lung disease in ADA-SCID		enzyme replacement		1
22350222	haematopoietic stem cell transplant		TREATS	metabolic abnormalities		Non-infectious lung disease in ADA-SCID		haematopoietic stem cell transplant	metabolic abnormalities	1
22350222	treating infectious complications		PREVENTS	worsening of Non-infectious lung disease		MONDO:0007064				1
26376800	biochemical diagnosis		TREATS	HP:0002721	Immune deficiency	MONDO:0007064				1
26376800	immunological diagnosis		TREATS	HP:0002721	Immune deficiency	MONDO:0007064				1
26376800	molecular diagnosis		TREATS	HP:0002721	Immune deficiency	MONDO:0007064				1
26376800	MAXO:0000747	Hematopoietic stem cell transplantation	TREATS	HP:0002721	Immune deficiency	MONDO:0007064		hematopoietic stem cells		1
26376800	enzyme replacement		TREATS	HP:0002721	Immune deficiency	MONDO:0007064		enzyme replacement		1
26376800	biochemical diagnosis		TREATS	metabolic deficiency		MONDO:0007064				1
26376800	immunological diagnosis		TREATS	metabolic deficiency		MONDO:0007064				1
26376800	molecular diagnosis		TREATS	metabolic deficiency		MONDO:0007064				1
26376800	MAXO:0000068	transplantation	TREATS	metabolic deficiency		MONDO:0007064		hematopoietic stem cell		1
26376800	enzyme replacement		TREATS	metabolic deficiency		MONDO:0007064		enzyme replacement		1
20039061	Late-onset adenosine deaminase deficiency presenting		IN	disease of the oral mucosa		MONDO:0009237	Late-onset	adenosine deaminase	benign, asymptomatic	1
20460637	bone marrow transplantation		TREATS	low donor stem cell chimerism		severe combined immunodeficiency		bone marrow transplantation		1
20460637	reduced intensity conditioning regimen		PREVENTS	low donor stem cell chimerism		MONDO:0015974		busulfan/fludarabine		1
20460637	MAXO:0010030	bone marrow transplantation	TREATS	reduced long-term immune reconstitution		MONDO:0015974				1
29620681	immune-modulation		TREATS	thrombocytopenia		Immune Thrombocytopenia	intravenous	immunoglobulin G		1
29620681	systemic corticosteroids		TREATS	HP:0001873	thrombocytopenia	MONDO:0002048		systemic corticosteroids		1
19337228	MAXO:0001001	gene therapy	TREATS	HP:0004430	Severe combined immunodeficiency	MONDO:0007064				1
34184208	lentiviral-transduced autologous CD34+ cells		TREATS	accumulation of toxic metabolites within lymphocytes		MONDO:0007064	carrying the ADA gene	lentiviral-transduced autologous CD34+ cells carrying the ADA gene		1
34184208	molecular monitoring in following B cell reconstitution		TREATS	low B cell numbers		MONDO:0007064				1
15032591	Bone marrow transplantation		TREATS	near absence of circulating mature CD3+ T cells		Severe Combined Immunodeficiency		Bone marrow transplantation		1
15032591	Bone marrow transplantation		TREATS	complete lack of gamma/delta T cells		Severe Combined Immunodeficiency				1
15032591	Bone marrow transplantation		TREATS	toxic accumulations of metabolites causing T cell apoptosis		Severe Combined Immunodeficiency				1
15032591	MAXO:0001001	gene therapy	TREATS	near absence of circulating mature CD3+ T cells		MONDO:0015974		Gene therapy		1
15032591	MAXO:0001001	gene therapy	TREATS	complete lack of gamma/delta T cells		MONDO:0015974				1
15032591	MAXO:0001001	gene therapy	TREATS	toxic accumulations of metabolites causing T cell apoptosis		MONDO:0015974		Gene therapy		1
16522790	stem cell gene therapy		TREATS	adenosine deaminase deficiency						1
21531016	MAXO:0001001	gene therapy	TREATS	adenosine deaminase deficiency						1
16037821	Transfer of drug resistance genes into hematopoietic stem cells		PREVENTS	Chemotherapy-induced myelosuppression		Hematopoietic stem cell disorders		drug resistance genes		1
16037821	Myeloprotection		PREVENTS	Chemotherapy-induced myelosuppression		Breast cancer, Lymphomas, Brain tumors, Testicular cancer				1
16037821	Selection of HSCs for correction of an inherited disorder		TREATS	X-linked severe combined immune deficiency, Adenosine deaminase deficiency, Thalassemia		Hematopoietic stem cell disorders				1
23812072	MAXO:0000747	Hematopoietic stem cell transplantation	TREATS	immune reconstitution		MONDO:0000922				1
23812072	MAXO:0001001	gene therapy	TREATS	immune reconstitution		MONDO:0000922		gene therapy		1
23812072	gene therapy		TREATS	infections		MONDO:0000922		gene therapy		1
23812072	preconditioning chemotherapy		PREVENTS	disappearance of gene-modified cells		MONDO:0000922	preconditioning	chemotherapy		1
23812072	usage of self-inactivating vectors		PREVENTS	lymphoproliferative syndrome		MONDO:0000922		self-inactivating vectors		1
27289360	ex vivo gene therapy		TREATS	HP:0001871	hematological disorders			gene therapy		1
9806008	MAXO:0001001	Gene therapy	TREATS	cystic fibrosis		MONDO:0009061				1
9806008	MAXO:0001001	Gene therapy	TREATS	HIV infection		MONDO:0005109				1
17928873	Retroviral-mediated gene therapy		TREATS	Severe combined immunodeficiency-X1 disease				Retroviral-mediated gene therapy		1
17928873	MAXO:0001001	gene therapy	TREATS	Adenosine deaminase deficiency			Retroviral-mediated	Retroviral-mediated gene therapy		1
14760277	MAXO:0010030	bone marrow transplantation	TREATS	HP:0004430	Severe combined immunodeficiency	Adenosine deaminase-deficient severe combined immunodeficiency				1
22348551	MAXO:0001001	Gene therapy	TREATS	absence of adenosine deaminase		MONDO:0007064				1
21375467	development		PREVENTS	genotoxicity		Genotoxicity		safer vectors		1
21375467	safer gene therapy protocols		PREVENTS	genotoxicity		Genotoxicity		gene therapy protocols		1
21375467	integration site analysis		PREVENTS	genotoxicity		Genotoxicity				1
21375467	development		PREVENTS	clonal expansion		Genotoxicity		safer vectors		1
21375467	safer gene therapy protocols		PREVENTS	clonal expansion		Genotoxicity		gene therapy protocols		1
21375467	integration site analysis		PREVENTS	clonal expansion		Genotoxicity				1
21375467	development		PREVENTS	HP:0001909	leukemia	Genotoxicity		safer vectors		1
21375467	safer gene therapy protocols		PREVENTS	HP:0001909	leukemia	Genotoxicity		gene therapy protocols		1
21375467	integration site analysis		PREVENTS	HP:0001909	leukemia	Genotoxicity				1
21843190	bone marrow transplant		TREATS	HP:0001888	lymphopenia	MONDO:0015974				1
21843190	bone marrow transplant		PREVENTS	HP:0031690	opportunistic infection	MONDO:0015974				1
22805442	bone marrow transplantation		TREATS	recurrent bronchitis		delayed-onset adenosine deaminase deficiency	with reduced intensity conditioning	reduced intensity conditioning		1
22805442	bone marrow transplantation		TREATS	bronchiectasia		delayed-onset adenosine deaminase deficiency	with reduced intensity conditioning	reduced intensity conditioning		1
22805442	bone marrow transplantation		TREATS	lymphopenia		delayed-onset adenosine deaminase deficiency	with reduced intensity conditioning	reduced intensity conditioning		1
22805442	bone marrow transplantation		TREATS	autoimmune thyroiditis		delayed-onset adenosine deaminase deficiency	with reduced intensity conditioning	reduced intensity conditioning		1
22805442	bone marrow transplantation		TREATS	neutropenia		delayed-onset adenosine deaminase deficiency	with reduced intensity conditioning	reduced intensity conditioning		1
22805442	engraftment		TREATS	delayed-onset adenosine deaminase deficiency						1
22805442	treatment		TREATS	delayed-onset adenosine deaminase deficiency			with busulfan	CHEBI:28901		1
22805442	treatment		TREATS	delayed-onset adenosine deaminase deficiency			with fludarabine	fludarabine		1
33374035	enzyme replacement therapy		TREATS	adenosine deaminase deficiency				enzyme replacement therapy		1
33374035	MAXO:0000747	allogenic or autologous hematopoietic stem cell transplantation (HSCT) with gene therapy	TREATS	adenosine deaminase deficiency			with gene therapy	gene therapy		1
33374035	haploidentical stem cell transplant		TREATS	adenosine deaminase deficiency		adenosine deaminase deficiency				1
33374035	prophylaxis		PREVENTS	graft-versus-host disease				CHEBI:4027		1
35643347	Enzyme replacement treatment		TREATS	Adenosine deaminase deficiency			with Adagen	Adagen		1
35643347	Enhanced solubilization of drug		PREVENTS	solubility issues		MONDO:0007064				1
35643347	Controlled release		PREVENTS	rapid metabolization		MONDO:0007064		Controlled release		1
35643347	Reduced immunogenicity		PREVENTS	immune response		Adenosine deaminase deficiency		Adenosine deaminase deficiency		1
35643347	Prolonged circulation		PREVENTS	quick elimination		MONDO:0007064				1
26602134	Urine Purine Metabolite Determination by UPLC-Tandem Mass Spectrometry		TREATS	HP:0034368	Urolithiasis	Inborn errors of purine metabolism				1
26602134	Urine Purine Metabolite Determination by UPLC-Tandem Mass Spectrometry		PREVENTS	Primary immune deficiency		Inborn errors of purine metabolism				1
26602134	UPLC-Tandem Mass Spectrometry		TREATS	Severe intellectual disability		Inborn errors of purine metabolism		Urine Purine Metabolite Determination		1
26602134	Urine Purine Metabolite Determination		TREATS	Neurological symptoms		Inborn errors of purine metabolism		UPLC-Tandem Mass Spectrometry		1
11435465	Ex vivo experiments		TREATS	TCR activation defects of T cells		MONDO:0015974				1
11435465	In vivo examination		TREATS	Severe depletion of T and B lymphocytes		MONDO:0015974				1
11435465	Ex vivo experiments		TREATS	T cell apoptosis in thymi		MONDO:0015974		CHEBI:16335		1
11435465	Ex vivo experiments		TREATS	Defects in T and B cell development		MONDO:0015974				1
29433935	MAXO:0001001	Gene therapy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	with Retroviral vector encoding the human ADA cDNA	Retroviral vector encoding the human ADA cDNA		1
29433935	MAXO:0001001	Gene therapy	TREATS	Impaired production and function of T, B, and NK cells		MONDO:0007064	with Retroviral vector encoding the human ADA cDNA	Retroviral vector encoding the human ADA cDNA		1
17614781	Autoimmune thyroiditis		TREATS	HP:0000872	Autoimmune thyroiditis	MONDO:0007064				1
17614781	Acquired hypothyroidism		TREATS	HP:0000832	Acquired hypothyroidism	MONDO:0007064				1
18597656	enzyme replacement therapy		TREATS	HP:0031690	opportunistic infections	MONDO:0007064		enzyme replacement therapy		1
18597656	bone marrow transplantation		TREATS	opportunistic infections		ADA-SCID				1
18597656	MAXO:0001001	gene therapy	TREATS	HP:0031690	opportunistic infections	MONDO:0007064	using retroviral vectors	retroviral vectors		1
18597656	MAXO:0001001	gene therapy	TREATS	HP:0031690	opportunistic infections	MONDO:0007064	recombinant adeno-associated virus-based	recombinant adeno-associated virus-based gene therapy		1
18597656	enzyme replacement therapy		TREATS	metabolic anomalies		MONDO:0007064		enzyme replacement therapy		1
18597656	MAXO:0010030	bone marrow transplantation	TREATS	metabolic anomalies		MONDO:0007064				1
18597656	MAXO:0001001	gene therapy	TREATS	metabolic anomalies		MONDO:0007064	using	retroviral vectors		1
18597656	MAXO:0001001	gene therapy	TREATS	metabolic anomalies		MONDO:0007064	recombinant adeno-associated virus-based	recombinant adeno-associated virus-based gene therapy		1
18597656	enzyme replacement therapy		TREATS	multiple organ system pathology		ADA-SCID		enzyme replacement therapy		1
18597656	bone marrow transplantation		TREATS	multiple organ system pathology		ADA-SCID		bone marrow transplantation		1
18597656	MAXO:0001001	gene therapy	TREATS	multiple organ system pathology		MONDO:0007064	using	retroviral vectors		1
18597656	MAXO:0001001	gene therapy	TREATS	multiple organ system pathology		MONDO:0007064	recombinant adeno-associated virus-based	recombinant adeno-associated virus-based gene therapy		1
24488786	Gene transfer into hematopoietic stem cells		TREATS	primary immunodeficiency diseases				gene transfer		1
24488786	Development and application of new generations		PREVENTS	HP:0002488	Acute leukemias	MONDO:0003778	new generations of	viral vectors		1
20493398	MAXO:0010030	bone marrow transplantation	TREATS	severe lymphopenia		MONDO:0007064				1
20493398	Enzyme replacement therapy		TREATS	severe lymphopenia		MONDO:0007064	with PEG-ADA	PEG-ADA		1
20493398	Autologous hematopoietic stem cell gene therapy		TREATS	severe lymphopenia		Adenosine deaminase deficiency	Autologous	hematopoietic stem cell gene therapy		1
9865602	T-cell-directed gene therapy		TREATS	ADA deficiency						1
9865602	stimulation with IL-4		TREATS	elevation of serum IgE level		MONDO:0007064	with IL-4	IL-4		1
9865602	stimulation with IL-4		TREATS	peripheral eosinophil count		MONDO:0007064	with IL-4	IL-4		1
21057082	MAXO:0000747	Hematopoietic stem cell transplantation	TREATS	accumulation of toxic metabolites		SCID		hematopoietic stem cell	toxic metabolites	1
21057082	enzyme replacement therapy		TREATS	accumulation of toxic metabolites		MONDO:0015974		pegylated bovine ADA (PEG-ADA)		1
21057082	MAXO:0000747	Hematopoietic stem cell transplantation	TREATS	decrease in circulating lymphocytes		MONDO:0015974		hematopoietic stem cell transplantation (HSCT)	CD19(+)	1
21057082	enzyme replacement therapy		PREVENTS	fatal outcome		MONDO:0015974	with pegylated bovine ADA (PEG-ADA)	pegylated bovine ADA (PEG-ADA)	fatal outcome in early infancy	1
21057082	MAXO:0000747	Hematopoietic stem cell transplantation	PREVENTS	T cell repertoires		SCID		hematopoietic stem cell	narrowing	1
21057082	enzyme replacement therapy		TREATS	narrowing T cell repertoires		MONDO:0015974		pegylated bovine ADA (PEG-ADA)		1
11060694	treatment		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		PEG-ADA		1
36464395	early detection		PREVENTS	overdiagnosis risk		MONDO:0007064				1
15236670	Haematopoietic stem cell transplantation		TREATS	life-threatening infections		Severe combined immune deficiency		Haematopoietic stem cell transplantation		1
15236670	Haploidentical transplants		TREATS	life-threatening infections		Severe combined immune deficiency		Haploidentical transplants		1
15236670	Retroviral gene delivery		TREATS	life-threatening infections		Severe combined immune deficiency		Retroviral gene delivery		1
15236670	Ex vivo gene transfer		TREATS	life-threatening infections		MONDO:0015974				1
28319446	Bone-marrow transplant		TREATS	symptoms		MONDO:0007064	from a matched related donor	Bone-marrow transplant	immunologic and nonimmunologic	1
28319446	Ex vivo gene therapy of patient bone-marrow CD34+ cells		TREATS	immunologic and nonimmunologic symptoms		MONDO:0007064		GSK2696273		1
36719776	Transamniotic fetal administration		PREVENTS	Inherited metabolic disorders			with Human adenosine deaminase (ADA)	genetically modified hematopoietic stem cells		1
36719776	Transamniotic fetal administration		PREVENTS	Hemoglobinopathies				genetically modified hematopoietic stem cells	with Human adenosine deaminase (ADA)	1
36719776	Transamniotic fetal administration of genetically modified hematopoietic stem cells		PREVENTS	HP:0002721	Immune deficiency		with Human adenosine deaminase (ADA)	CHEBI:39048		1
10048399	autologous lymphocytes transduced with a human ADA gene		TREATS	adenosine deaminase deficiency		MONDO:0015974				1
24471251	In vivo modification		TREATS	gene-related diseases						1
24471251	Ex vivo modification		TREATS	gene-related diseases						1
24471251	Gene transfer protocols		TREATS	diseases		gene-related	with Retrovirus	Retrovirus	gene-related	1
24471251	Gene transfer protocols		TREATS	gene-related diseases			with Adenovirus	Adenovirus		1
24471251	Gene transfer protocols		TREATS	gene-related diseases		N/A	with Adeno-associated virus	Adeno-associated virus	N/A	1
31261096	Newborn screening		PREVENTS	increased risk of infections		MONDO:0015974				1
31261096	Protective isolation		PREVENTS	increased risk of infections		MONDO:0015974				1
31261096	Initiation of prophylactic antimicrobials		PREVENTS	increased risk of infections		MONDO:0015974	prophylactic	CHEBI:33281		1
31261096	blood product transfusions		PREVENTS	increased risk of infections		Severe Combined Immunodeficiency	Caution with	blood product		1
31261096	Avoidance of live vaccinations		PREVENTS	increased risk of infections		Severe Combined Immunodeficiency		live vaccinations		1
31261096	MAXO:0010030	bone marrow transplantation	TREATS	abnormal T-cell maturation		MONDO:0015974				1
31261096	MAXO:0000068	transplantation	TREATS	abnormal T-cell maturation		MONDO:0015974		Stem cell		1
31261096	Enzyme replacement		TREATS	abnormal T-cell maturation		Severe Combined Immunodeficiency		Enzyme		1
31261096	MAXO:0001001	Gene therapy	TREATS	abnormal T-cell maturation		MONDO:0015974		Gene therapy		1
26730942	Directed differentiation of murine PSCs		PREVENTS	abnormal pathology		Airway disease				1
26730942	intratracheal transplantation		TREATS	acute lung injury		Airway disease		alveolar-like macrophages		1
26730942	intratracheal transplantation		PROMOTES	recovery		Airway disease		alveolar-like macrophages	with granulocyte-macrophage colony-stimulating factor	1
10942363	stem cell transplantation		TREATS	severe immunodeficiency states		congenital immunodeficiencies	with fludarabine-melphalan-anti-lymphocyte globulin	fludarabine-melphalan-anti-lymphocyte globulin		1
10942363	conditioning therapy		TREATS	severe organ dysfunction		congenital immunodeficiencies				1
10942363	conditioning therapy		PREVENTS	acute graft-versus-host disease (GVHD)		congenital immunodeficiencies				1
10942363	nonmyeloablative preparative regimen		TREATS	immunodeficiency states		congenital immunodeficiencies		nonmyeloablative preparative regimen	severe	1
10942363	engraftment		TREATS	severe immunodeficiency states		congenital immunodeficiencies				1
10942363	immune reconstitution		TREATS	severe immunodeficiency states		congenital immunodeficiencies				1
33359138	long-term enzyme replacement therapy		TREATS	adenosine deaminase deficiency			long-term	enzyme replacement therapy		1
11434885	Hematopoietic stem-cell transplantation		TREATS	primary immunodeficiencies						1
11434885	Hematopoietic stem-cell transplantation		TREATS	primary immunodeficiencies			with colony stimulating factors	colony stimulating factors		1
11783525	Carrier erythrocyte entrapped adenosine deaminase therapy		TREATS	Adenosine deaminase deficiency				adenosine deaminase		1
38355973	Autologous CD34+ cell gene therapy		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	following busulfan reduced-intensity conditioning	CHEBI:28901		1
38355973	enzyme replacement therapy		PREVENTS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	Long-term	enzyme replacement therapy		1
38355973	MAXO:0001479	Allogeneic hematopoietic stem cell transplantation	PREVENTS	HP:0004430	severe combined immunodeficiency	MONDO:0007064				1
24578017	Newborn screening		PREVENTS	T-cell impairment		MONDO:0015974				1
24578017	Molecular screen for TRECs		DETECTS	Low or borderline TRECs		MONDO:0015974		TRECs	Low or borderline	1
24578017	Diagnostic evaluation		DETECTS	T-cell impairment		MONDO:0015974				1
24578017	Flow cytometry		DETECTS	Adenosine deaminase deficiency		MONDO:0015974		Adenosine deaminase		1
24578017	MAXO:0001006	CBC (Complete Blood Count)	DETECTS	IL2RG-related SCID		MONDO:0015974		CBC (Complete Blood Count)		1
24578017	Diagnostic evaluation		DETECTS	Idiopathic T-cell lymphopenia		MONDO:0015974				1
26876279	Newborn screening		PREVENTS	death		MONDO:0015974				1
26876279	Treatment		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0015974	with	adenosine deaminase		1
30194989	enzyme replacement therapy		TREATS	HP:0002721	immunodeficiency	MONDO:0007064		enzyme replacement therapy (ERT)		1
30194989	allogeneic hematopoietic stem cell transplantation		TREATS	immune deficiency		severe combined immune deficiency		allogeneic hematopoietic stem cell transplantation	adenosine deaminase deficiency	1
30194989	HSC-GT		TREATS	immune deficiency		severe combined immune deficiency caused by adenosine deaminase deficiency		gammaretrovirus-mediated autologous hematopoietic stem cell gene therapy		1
30194989	HSC-GT		TREATS	HP:0002721	immunodeficiency	severe combined immune deficiency caused by adenosine deaminase deficiency		lentivirus-mediated autologous hematopoietic stem cell gene therapy		1
30194989	HSCT		TREATS	immune deficiency		severe combined immune deficiency	with alternative donors	alternative donors	adenosine deaminase deficiency	1
23897312	Newborn screening		PREVENTS	delay in diagnosis		MONDO:0015974		Newborn screening		1
23897312	Evaluation of clinical and laboratory findings		TREATS	overlooked symptoms		MONDO:0015974				1
14607964	investigation of B cell deficiency		TREATS	impaired B cell development		MONDO:0007064				1
22198747	Developing safer vectors		PREVENTS	clonal expansion		Insertional mutagenesis		safer vectors		1
22198747	Developing safer vectors		PREVENTS	development of leukemia		Insertional mutagenesis		Insertional mutagenesis		1
22198747	Lower-risk gene therapy protocols		PREVENTS	clonal expansion		Insertional mutagenesis	Lower-risk	gene therapy protocols		1
22198747	Lower-risk gene therapy protocols		PREVENTS	development of leukemia		Insertional mutagenesis	Lower-risk	gene therapy protocols		1
22198747	Predicting genotoxicity		PREVENTS	clonal expansion		Insertional mutagenesis				1
22198747	Predicting genotoxicity		PREVENTS	development of leukemia		Insertional mutagenesis				1
22198747	Mapping vector integration sites		PREVENTS	clonal expansion		Insertional mutagenesis				1
22198747	Mapping vector integration sites		PREVENTS	development of leukemia		Insertional mutagenesis				1
22198747	Minimizing genotoxicity		PREVENTS	clonal expansion		Insertional mutagenesis				1
22198747	Minimizing genotoxicity		PREVENTS	development of leukemia		Insertional mutagenesis				1
15773344	Gene therapy protocol targeting peripheral blood lymphocytes (PBLs)		TREATS	low levels of CD8+ T lymphocytes		MONDO:0015974				1
15773344	MAXO:0000757	Infusion	TREATS	low serum immunoglobulin		MONDO:0015974		autologous PBLs transduced with retroviral vector LASN encoding ADAcDNA		1
15773344	MAXO:0000757	Infusion	TREATS	lack of specific antibodies		MONDO:0015974		autologous PBLs transduced with retroviral vector LASN encoding ADAcDNA	specific	1
15773344	MAXO:0000757	Infusion	TREATS	delayed type hypersensitivity skin tests		MONDO:0015974	autologous	autologous PBLs transduced with retroviral vector LASN encoding ADAcDNA	negative delayed type hypersensitivity skin tests	1
15773344	Treatment		TREATS	systemic toxicity		MONDO:0015974		PEG-ADA		1
15773344	Treatment		TREATS	poor liver function		MONDO:0015974		PEG-ADA		1
15773344	Treatment		TREATS	systemic toxicity		MONDO:0015974		autologous bone marrow CD34+ cells engineered with retroviral vector GCsapM-ADA		1
15773344	Treatment		TREATS	poor liver function		MONDO:0015974		autologous bone marrow CD34+ cells engineered with retroviral vector GCsapM-ADA		1
23583799	Gene therapy		TREATS	T cell immunodeficiencies		Severe Combined Immunodeficiencies		Gene therapy		1
23583799	Use of self inactivated (SIN) retro(or lenti) viruses		TREATS	T cell immunodeficiencies		MONDO:0015974		self inactivated (SIN) retro(or lenti) viruses		1
23179487	enzyme replacement therapy		TREATS	scapular spurring		ADA-deficiency SCIDS		adenosine deaminase		1
23179487	enzyme replacement therapy		TREATS	HP:0000907	anterior rib cupping	ADA-deficiency SCIDS	with adenosine deaminase	adenosine deaminase		1
19776764	MAXO:0000747	allogenic or autologous hematopoietic stem cell transplantation (HSCT) with gene therapy	TREATS	Primary Immunodeficiencies (PID)		NULL	NULL	NULL	NULL	1
19776764	MAXO:0001001	Gene therapy	TREATS	Primary Immunodeficiencies		MONDO:0000922				1
19776764	pre-conditioning with chemotherapy		PREVENTS	graft-versus-host disease		MONDO:0000922		chemotherapy		1
19776764	detailed characterization of retroviral vector integration profiles		PREVENTS	adverse events		MONDO:0000922		retroviral vector		1
19776764	design of self-inactivating retroviral and lentiviral vectors		PREVENTS	adverse events		MONDO:0000922		gene therapy		1
31812707	Enzyme replacement therapy		TREATS	severe immunodeficiency		MONDO:0007064		Enzyme replacement therapy		1
31812707	Enzyme replacement therapy		TREATS	very low lymphocyte counts		MONDO:0007064		Enzyme replacement therapy		1
31812707	Enzyme replacement therapy		TREATS	impaired T cell function		MONDO:0007064		Enzyme replacement therapy (ERT)		1
25875699	Stem cell gene therapy		TREATS	lack of functional ADA enzyme		Adenosine deaminase-deficiency	with gamma-retroviral vector GCsapM-ADA	gamma-retroviral vector GCsapM-ADA		1
25875699	Stem cell gene therapy		TREATS	compromised immunity		Adenosine deaminase-deficiency		Stem cell gene therapy		1
25875699	Enzyme replacement therapy		PREVENTS	compromised immunity		Adenosine deaminase-deficiency		Enzyme replacement therapy		1
23280131	tandem mass spectrometry analysis of dried blood spots		TREATS	progressive immunodeficiency		late-onset adenosine deaminase deficiency				1
23280131	real-time PCR quantification of TRECs		TREATS	progressive immunodeficiency		late-onset adenosine deaminase deficiency				1
35914665	Newborn screening (NBS)		PREVENTS	complications of the disease		MONDO:0007064		T cell receptor excision circles (TREC)		1
35914665	tandem mass spectroscopy screening		PREVENTS	complications of the disease		MONDO:0007064				1
35914665	dried blood spot NBS		PREVENTS	complications of the disease		MONDO:0007064				1
35914665	biochemical and genetic testing		TREATS	adenosine deaminase deficiency						1
27056559	MAXO:0001001	Gene therapy	TREATS	Primary Immune Deficiencies						1
27056559	Autologous transplant		TREATS	Primary Immune Deficiencies						1
27056559	Stem cell culturing techniques		TREATS	Primary Immune Deficiencies						1
27056559	Site-specific genome editing		TREATS	Primary Immune Deficiencies						1
21271505	enzyme replacement		TREATS	HP:0002904	Hyperbilirubinemia	MONDO:0007064	with pegylated ADA	pegylated ADA		1
21271505	MAXO:0010030	bone marrow transplantation	PREVENTS	rapid fatal hepatic failure		MONDO:0007064				1
21271505	gene therapy		TREATS	Severe Combined Immunodeficiency		ADA-SCID				1
20534204	MAXO:0001001	Gene therapy	TREATS	deficient immune function		MONDO:0015974				1
20534204	MAXO:0001001	Gene therapy	TREATS	high concentration of toxic metabolites		MONDO:0015974		Gene therapy		1
20534204	Enzyme-replacement therapy		PREVENTS	deficient immune function		MONDO:0015974	with adenosine deaminase	adenosine deaminase		1
19638621	Haematopoietic stem cell transplantation		TREATS	Severe combined immunodeficiency		Adenosine deaminase deficiency		Haematopoietic stem cell transplantation		1
19638621	Enzyme replacement therapy		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	with	Pegylated bovine ADA		1
19638621	Autologous haematopoietic stem cell gene therapy		TREATS	Severe combined immunodeficiency		Adenosine deaminase deficiency	Autologous	haematopoietic stem cell gene therapy		1
19638621	Matched sibling donor transplants		TREATS	Severe combined immunodeficiency		Adenosine deaminase deficiency		Adenosine deaminase deficiency		1
19638621	Mismatched parental donor transplants		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064				1
17185467	MAXO:0000747	allogenic or autologous hematopoietic stem cell transplantation (HSCT) with gene therapy	TREATS	HP:0002721	immunodeficiency	MONDO:0007064				1
17185467	Hematopoietic stem cell transplantation		FAILS TO CONTROL	CNS complications		MONDO:0007064		Hematopoietic stem cell transplantation	CNS complications	1
20493400	Gene therapy		TREATS	immunologic impairment		Adenosine deaminase deficiency		Gene therapy		1
20493400	MAXO:0001001	Gene therapy	TREATS	metabolic abnormalities		MONDO:0007064		Gene therapy	metabolic abnormalities	1
20493400	Allogeneic bone marrow transplant		TREATS	immunologic impairment		MONDO:0007064				1
20493400	Enzyme replacement therapy		TREATS	metabolic abnormalities		MONDO:0007064				1
20493400	MAXO:0000757	Infusion	TREATS	immunologic impairment		MONDO:0007064		autologous hematopoietic stem cells corrected ex vivo by retroviral vectors		1
20493400	Low-intensity conditioning regimen		TREATS	immunologic impairment		MONDO:0007064		Low-intensity conditioning regimen		1
17765813	Enzyme replacement		TREATS	Severe immunodeficiency		MONDO:0007064		Enzyme replacement		1
17765813	Allogeneic bone marrow transplantation		TREATS	Severe immunodeficiency		MONDO:0007064				1
17765813	Computed tomographic scans		TREATS	Volume loss in brain		Adenosine deaminase deficiency		Computed tomographic scans		1
17765813	Cranial MRI		TREATS	Abnormalities of basal ganglia and thalamus		MONDO:0007064				1
17765813	Detailed neurologic and neuroimaging evaluation		TREATS	HP:0000707	Neurologic abnormalities	MONDO:0007064				1
10886203	Enzyme replacement therapy		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	with Polyethylene glycol-conjugated adenosine deaminase	Polyethylene glycol-conjugated adenosine deaminase		1
10886203	Entrapment within human energy-replete carrier erythrocytes using a hypo-osmotic dialysis procedure		PREVENTS	Severe combined immunodeficiency		adenosine deaminase deficiency		adenosine deaminase deficiency		1
36736952	Newborn screening		PREVENTS	infections		MONDO:0007064				1
36736952	Enzyme replacement therapy (ERT)		TREATS	infections		MONDO:0007064		Enzyme replacement therapy		1
36736952	Allogeneic hematopoietic cell transplantation		TREATS	infections		Adenosine Deaminase Deficiency		Allogeneic hematopoietic cell transplantation		1
36736952	Autologous ADA gene therapy with nonmyeloablative conditioning and ERT withdrawal		TREATS	infections		MONDO:0007064	Autologous	ADA gene therapy		1
36736952	Hematopoietic cell transplantation		TREATS	infections		MONDO:0007064	using HLA-mismatched family-related donors	Hematopoietic cell transplantation		1
36736952	Hematopoietic cell transplantation		TREATS	infections		MONDO:0007064	after reduced-intensity conditioning	HLA-matched unrelated donors		1
17300989	Hematopoietic stem cell transplantation		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		Hematopoietic stem cell		1
17300989	Enzyme replacement therapy		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	with PEG-ADA	PEG-ADA		1
17300989	MAXO:0001001	Gene therapy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		Gene therapy		1
17300989	Immunoglobulin replacement		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064		Immunoglobulin replacement		1
17586199	replacement		TREATS	metabolic abnormalities		MONDO:0015974		polyethylene glycol-linked ADA		1
17586199	replacement		PREVENTS	further deterioration of cellular immunity		MONDO:0015974		polyethylene glycol-linked ADA		1
17721875	Use of genetically corrected hematopoietic stem cells		TREATS	adenosine deaminase deficiency		MONDO:0007064		genetically corrected hematopoietic stem cells		1
17721875	Use of oncolytic adenoviruses		TREATS	HP:0002664	cancer	MONDO:0004992		oncolytic adenoviruses		1
17721875	Use of targeted T cells		TREATS	HP:0002664	cancer	MONDO:0004992		targeted T cells		1
17721875	Clinical gene therapy trials		TREATS	HP:0012125	prostate cancer	MONDO:0008315		gene therapy		1
30918508	Enzyme Replacement Therapy		TREATS	HP:0000365	Hearing impairment	MONDO:0007064	with Polyethylene glycol conjugated ADA	Polyethylene glycol conjugated ADA		1
30918508	Enzyme Replacement Therapy		TREATS	Abnormal hearing thresholds at low and medium tone frequencies		MONDO:0007064	with Polyethylene glycol conjugated ADA	Polyethylene glycol conjugated ADA		1
30918508	Enzyme Replacement Therapy		TREATS	Damage to cochlear hair cells		MONDO:0007064	with Polyethylene glycol conjugated ADA	Polyethylene glycol conjugated ADA		1
30918508	Enzyme Replacement Therapy		TREATS	Progressive immune abnormalities		MONDO:0007064	with Polyethylene glycol conjugated ADA	Polyethylene glycol conjugated ADA		1
26122173	enzyme replacement therapy		TREATS	immune dysfunction		MONDO:0007064		enzyme replacement therapy		1
12901330	stem cell manipulation		TREATS	primary immunodeficiencies						1
38033164	Gene therapy		TREATS	Pan-lymphopenia		Severe combined immune deficiency due to adenosine deaminase deficiency (ADA SCID)	with a normal human ADA gene added to autologous hematopoietic stem cells (HSC)	a normal human ADA gene		1
38033164	Gene therapy		TREATS	Accumulated		Severe combined immune deficiency due to adenosine deaminase deficiency (ADA SCID)	with a normal human ADA gene added to autologous hematopoietic stem cells (HSC)	ADA gene	cytotoxic adenine metabolites	1
12196037	allogeneic bone marrow transplantation		TREATS	incomplete restoration of B cell function		MONDO:0015974		allogeneic bone marrow transplantation (BMT)		1
12196037	genetic correction of peripheral T lymphocytes		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0015974				1
12196037	haematopoietic stem cell (HSC) correction		TREATS	HP:0004430	severe combined immunodeficiency			retrovirally mediated gene transfer		1
12196037	gene therapy trial		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0010315				1
12196037	allogeneic bone marrow transplantation		PREVENTS	severe complications such as graft-versus-host disease		MONDO:0015974				1
10202239	MAXO:0001001	Gene therapy	TREATS	Severe combined immunodeficiency caused by adenosine deaminase deficiency		MONDO:0015974		gene therapy		1
10202239	T cell-directed gene transfer		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0015974		T cell-directed gene transfer		1
10202239	gene transfer to hematopoietic stem cells		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0015974	retroviral-mediated	retroviral		1
21624615	MAXO:0001001	Gene therapy	TREATS	Underlying T-cell immunodeficiency		MONDO:0015974		Gene therapy		1
21624615	MAXO:0001001	Gene therapy	PREVENTS	HP:0001909	leukemia	MONDO:0015974		Gene therapy		1
10082448	polymerase chain-reaction technique		PREVENTS	graft failure		MONDO:0013730		polymerase chain-reaction technique		1
10082448	immunomagnetically isolated leukocyte populations assay		PREVENTS	engraftment failure		MONDO:0013730				1
10082448	polymerase chain-reaction technique		PREVENTS	secondary lymphoma		MONDO:0013730				1
10082448	polymerase chain-reaction technique		PREVENTS	relapse		MONDO:0013730		polymerase chain-reaction technique		1
10082448	immunomagnetically isolated leukocyte populations assay		PREVENTS	mixed chimerism		MONDO:0013730				1
15766024	Monitoring of growth, diet, personal hygiene, and life habits		PREVENTS	infections		Primary immune defects				1
15766024	Prevention		PREVENTS	infections		Primary immune defects				1
15766024	Early detection		TREATS	infections		Primary immune defects				1
15766024	Treatment of infections		TREATS	infections		Primary immune defects				1
15766024	Immunoglobulin substitution		TREATS	antibody defects		Primary immune defects	with Immunoglobulin	Immunoglobulin		1
15766024	Enzyme replacement		TREATS	adenosine deaminase defect		Primary immune defects	with Adenosine deaminase	Adenosine deaminase		1
15766024	MAXO:0010030	bone marrow transplantation	TREATS	numerous primary immune defects		Primary immune defects				1
15766024	MAXO:0001001	Gene therapy	TREATS	severe combined immunodeficiency on the X-chromosome (X-SCID), adenosine deaminase deficiency (ADA deficiency)		Primary immune defects		Gene therapy		1
23566838	Ex-vivo transfer		TREATS	PIDs				therapeutic transgene		1
23566838	Autologous hematopoietic stem cell transplantation		TREATS	PIDs						1
23566838	Conditioning		TREATS	PIDs						1
23566838	Pre-clinical investigation		PREVENTS	Malignant outcomes		PIDs		Pre-clinical investigation		1
29690908	Enzyme replacement therapy		TREATS	Persistent infection		MONDO:0007064		Enzyme replacement therapy		1
29690908	Enzyme replacement therapy		TREATS	Pulmonary insufficiency		Adenosine deaminase deficiency		Enzyme replacement therapy		1
29690908	Hematopoietic stem cell transplant		TREATS	Persistent infection		MONDO:0007064				1
29690908	Hematopoietic stem cell transplant		TREATS	HP:0010444	Pulmonary insufficiency	MONDO:0007064		Hematopoietic stem cell transplant		1
29690908	Gene addition techniques		TREATS	Persistent infection		Adenosine deaminase deficiency		Gene addition techniques		1
29690908	Gene addition techniques		TREATS	HP:0010444	Pulmonary insufficiency	MONDO:0007064				1
16752313	hematopoietic stem cell therapy		TREATS	ADA-SCID			with adenosine deaminase	adenosine deaminase		1
27763769	Stem cell transplantation		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064				1
27763769	MAXO:0001001	Gene therapy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064				1
27763769	Strimvelis		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0007064	with Strimvelis	Strimvelis		1
12820000	Excision of subcutaneous nodule		TREATS	Small subcutaneous nodule		Giant-cell fibroblastoma				1
10845921	Investigation of mechanisms of adenosine effects on murine thymocytes		TREATS	T-cell depletion		MONDO:0015974		CHEBI:16335		1
10845921	Induction of apoptosis		TREATS	Accumulation of intracellular and extracellular adenosine		MONDO:0015974	with Adenosine	CHEBI:16335		1
10845921	Inhibition of T-cell receptor (TCR)-induced activation		TREATS	T-cell depletion		MONDO:0015974				1
22622038	Enzyme replacement therapy		TREATS	autoimmune complications		MONDO:0007064		Enzyme replacement therapy	autoimmune complications	1
22622038	Bone marrow transplant		TREATS	autoantibody production		MONDO:0007064				1
22622038	MAXO:0001001	Gene therapy	TREATS	autoantibody production		MONDO:0007064	HSC	HSC-GT		1
22622038	MAXO:0001001	Gene therapy	TREATS	Anti-nuclear antibodies (ANAs)		MONDO:0007064	HSC	HSC-GT		1
23618815	Approval		TREATS	Gene therapy-related diseases				Glybera		1
23618815	Gene therapy trials		TREATS	Gene therapy-related diseases						1
23618815	Development of gene transfer vectors		TREATS	Gene therapy-related diseases				gene transfer vectors		1
22409989	Bronchoalveolar lavage (BAL)		TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0001437				1
22409989	MAXO:0000380	Lung biopsy	TREATS	HP:0004430	severe combined immunodeficiency	MONDO:0001437				1
22409989	Enzyme replacement		TREATS	Homogeneous granular eosinophilic material in alveolar spaces		MONDO:0001437	with Adenosine deaminase (ADA) coupled to Polyethylene glycol	CHEBI:39048		1
22409989	Allogeneic hematopoietic stem cell transplantation		TREATS	Homogeneous granular eosinophilic material in alveolar spaces		Pulmonary alveolar proteinosis		hematopoietic stem cell	alveolar	1
